LEO 39652 is a dual-soft PDE4 inhibitor with IC 50 s of 1.2 nM, 1.2 nM, 3.0 nM and 3.8 nM for PDE4A , PDE4B , PDE4C and PDE4D , respectively. LEO 39652 also inhibits TNF-α with an IC 50 value of 6.0 nM. LEO 39652 is used for topical research of Atopic dermatitis (AD)
In Vitro
LEO 39652 shows unbound in vitro potency when measured as LPS induced TNF-α release in human peripheral blood mononuclear cells (PBMC), incubated in serum free medium. LEO 39652 shows a relatively high binding to human serum albumin. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
LEO 39652 is inactivated both in blood and liver (dual-soft) while stabled in the skin .\nPharmacokinetic Analysis LEO 39652 exhibits total clearance (rats 930, minipigs 200 and monkey 300 mL/min/kg) and ratio to total AUC (rats 4, minipigs 6 and monkey 6 %) following intravenous administration (rats 0.075, minipigs 0.5 and monkeys 2.0 mg/kg) . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: 3 male Sprague Dawley rats, 2 female Göttingen minipigs, 2 male Göttingen minipigs, 2 female cynomolgus monkeys and 2 male cynomolgus monkeys Dosage: Rats 0.075, minipigs 0.5 and monkeys 2.0 mg/kg Administration: Intravenous injection Result: Total clearance of 930, 200 and 300 mL/min/kg for rats, minipigs and monkeys, respectively.
LEO 39652 is a dual-soft PDE4 inhibitor with IC 50 s of 1.2 nM, 1.2 nM, 3.0 nM and 3.8 nM for PDE4A , PDE4B , PDE4C and PDE4D , respectively. LEO 39652 also inhibits TNF-α with an IC 50 value of 6.0 nM. LEO 39652 is used for topical research of Atopic der
Conditions de stockage de stockage
Store at -80°C
Expédié en
Dry ice packs + Cold packs
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculateurs de solution
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Avis
Avis des clients
Application Protocols
No validated application protocols are provided for this item.
Item-specific tested applications: Not specified for this item; refer to CoA/Spec Sheet.
General protocols for small-molecule testing (not item-specific):
Preparation of 10 mM DMSO stock: Weigh the appropriate mass in a low-bind vial, add dry DMSO to volume, vortex until clear, and aliquot into single-use portions.
Serial dilution: Prepare intermediate DMSO dilutions (e.g., 10-point 1:3 series), then dilute into assay buffer to achieve final test concentrations, maintaining constant vehicle.
Control setup: Include vehicle-only controls and positive reference inhibitors/activators when available. Run at least n=3 technical replicates.
Data quality: Monitor Z′-factor for HTS, check for outliers due to precipitation or plate-edge effects, and confirm hits in orthogonal assays.
Storage of working solutions: Use freshly prepared dilutions; avoid multiple freeze–thaw cycles of DMSO stocks.
Consult the SDS and CoA for any item-specific constraints.
Biological Roles
Specific biological roles, targets, or pathways for LEO 39652 are not provided.
Item-specific:
Target/Mechanism: Not specified for this item; refer to CoA/Spec Sheet or primary literature.
General notes for small-molecule screening compounds (not item-specific):
Such molecules may serve as chemical probes or starting points in phenotypic or target-based screens. Any inferred biological role must be validated experimentally (binding assays, enzyme kinetics, cellular phenotypes, genetic rescue).
Off-target assessment using counterscreens and profiling panels (e.g., kinome, GPCRs, ion channels) is recommended to establish selectivity.
ADME pilot profiling (solubility, permeability, metabolic stability, plasma protein binding) can contextualize observed bioactivity but is outside the scope of this product listing and not specified.
No biological claims are made for this product. It is for research use only.
Buffer Applications
As a small-molecule library compound, LEO 39652 is not a buffer component. However, practical buffer considerations are important for assay deployment.
Item-specific buffer role: Not applicable.
General guidance (not item-specific):
Use assay-appropriate buffers (e.g., HEPES, Tris, PBS) with minimal organic cosolvent. Maintain ionic strength and pH compatible with the target biology.
Include 0.01–0.05% non-ionic surfactant (e.g., Tween-20) to reduce nonspecific adsorption/aggregation if compatible with the readout.
Pre-equilibrate buffers to assay temperature to avoid solubility shocks when adding DMSO stocks.
For pH-sensitive targets, confirm that compound addition (vehicle and volume) does not perturb pH or osmolality.
Recipes/ranges (literature, general):
HEPES buffer 10–50 mM, pH 7.0–7.5; Tris buffer 10–50 mM, pH 7.4–8.0; PBS 1×, pH ~7.4. Adjust based on your target system.
Green Alternatives
Green chemistry considerations apply primarily to solvent choice and handling during assay preparation, as the compound itself is fixed.
Not item-specific:
Prefer water-based assay buffers with minimal DMSO (≤0.5–1% v/v) when performance permits.
When co-solvents are necessary, consider ethanol or 2-propanol as greener alternatives to DMF/NMP, acknowledging their lower solvency for highly lipophilic compounds.
Comparison (general):
DMSO: excellent solvency; moderate environmental impact; good worker safety profile; common in bioassays.
DMF/NMP: powerful polar aprotic solvents but with more stringent EH&S concerns; avoid if possible.
Ethanol/2-propanol: greener, but limited solubility for some scaffolds; flammable.
Acetonitrile: volatile and flammable; relatively low toxicity but petrochemical origin; use sparingly.
Waste minimization:
Use microscale dissolutions and miniaturized assay formats (384–1536 well) to reduce solvent waste.
Employ sealed, low-dead-volume reservoirs and pre-chilled blocks to limit evaporation and repeated preparation cycles.
Packaging/materials:
Reuse cold-chain shippers where possible and consolidate shipments to reduce dry ice consumption.
Trade-offs should be balanced against assay reliability and compound integrity.
Pharmaceutical Uses
This product is supplied strictly for research use and is not intended for human or veterinary applications.
Item-specific regulatory/excipient status: Not specified for this item; refer to CoA/Spec Sheet. No pharmacopeial monograph is indicated.
General (not item-specific):
In early discovery, small molecules like this may be evaluated for developability attributes (solubility, stability). Any formulation exploration (e.g., enabling co-solvents, cyclodextrins, lipid vehicles) should be conducted under research conditions only.
No claims are made regarding safety, efficacy, or suitability as a drug substance or excipient.
No medical or clinical claims are associated with this listing.
Physical Properties
Given the absence of a disclosed structure and analytical specifications, definitive physicochemical parameters cannot be listed here.
Item-specific (from Product Data):
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
Literature/computed (typical guidance for small molecules; not item-specific):
Melting point, solubility profile, logP/logD, pKa, and refractive index should be determined from authoritative databases (e.g., PubChem entry for CID 71611998) or measured in-house for your intended experimental conditions.
Practical guidance (general):
Solubility screening: test DMSO at 10–50 mM, then dilute into assay buffer (final DMSO ≤0.5–1% v/v when possible). If precipitation occurs, consider co-solvents (acetonitrile, ethanol) at low percentages or adjust pH if ionizable groups are present.
Hygroscopicity/photolability: status is unknown; handle under low humidity and subdued light until confirmed.
Particle size/polymorph: Not specified; if solid, consider brief sonication or gentle heating (≤40 °C) during dissolution to aid wetting.
Values not provided: BP, MP, density, solubility in common solvents, logP/logD, pKa, UV-Vis properties, and stability indices are Not specified for this item; refer to CoA/Spec Sheet or measure experimentally.
Quality and Grades
Quality information specific to this item is not disclosed in the provided data.
Item-specific (from Product Data):
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
What to expect for small-molecule screening compounds (general, not item-specific):
Typical library-grade materials are supplied at ≥90–95% purity by LC or HPLC with MS identity confirmation; some programs require ≥95–98% purity. Verify on the CoA for this lot.
Identity confirmation may include 1H NMR, LC–MS, and HRMS. Residual solvents, water content (KF), and inorganic impurities may be reported; values are Not specified for this item.
If provided as a DMSO solution (not indicated here), concentration and water content are critical parameters; here, solution state is Not specified for this item.
Practical notes:
If your application is biophysical or biochemical (SPR, ITC, enzymology), consider performing in-house purity checks and orthogonal identity confirmation.
If low UV background or fluorescence purity is required, request UV/fluorescence scans from the vendor or run baseline measurements in your assay matrix.
Reaction and Applications
This product is listed as a small-molecule library compound rather than a synthetic reagent. Therefore, classical synthetic reaction applications (e.g., cross-couplings, oxidations) are not typically the intended use.
Item-specific:
Manufacturer Applications: Not specified for this item; refer to CoA/Spec Sheet.
Research usage (general for library compounds):
High-throughput screening (HTS), fragment or lead discovery, phenotypic assays, chemogenomics, target deconvolution workflows, and validation studies in cell-free or cellular systems.
Counter-screening and assay interference assessment (e.g., PAINS, redox activity, aggregation) should be conducted as standard diligence. No specific flags are provided for this item.
Practical tips:
Prepare concentrated DMSO stocks and perform serial dilutions immediately before use to limit freeze–thaw stress.
Assess stability under assay conditions (pH, temperature, light, redox environment) by LC–MS time-course if the experimental window exceeds a few hours.
Include vehicle controls and orthogonal readouts to detect fluorescence/absorbance interference.
Not applicable here:
Named organic reactions, catalyst systems, and stoichiometric reactivity are not addressed due to lack of structural information.
Reaction Conditions
Conventional synthetic reaction conditions are not applicable because LEO 39652 is offered as a test compound rather than a reagent.
Not applicable: Named reactions, catalysts, and stoichiometries cannot be recommended absent structural information.
Practical conditions for handling in assays (general, not item-specific):
Stock preparation: Dissolve in anhydrous DMSO at 10–50 mM. Vortex/sonicate briefly; avoid heating above 40 °C.
Working solutions: Dilute into assay buffer to the desired final concentration, keeping DMSO ≤0.5–1% v/v unless your system tolerates more.
Stability checks: Run LC–MS at t0 and at the end of the assay window to confirm chemical integrity and absence of reactive degradation.
Adsorption control: Use low-bind plasticware or glass; pre-rinse with diluted compound solution if nonspecific loss is suspected.
Safety and Handling
This product is intended for research use only. In the absence of explicit hazard classification, adopt a conservative laboratory safety posture.
Item-specific (from Product Data):
GHS Classification: Not specified for this item; refer to SDS.
Signal Word: Not specified for this item; refer to SDS.
H-Statements: Not specified for this item; refer to SDS.
Pictograms: Not specified for this item; refer to SDS.
Storage: Store at −80 °C. Shipped on dry ice packs + cold packs.
General handling guidance (defer to SDS for authoritative details):
PPE: lab coat, safety glasses, disposable nitrile gloves (double-glove for DMSO solutions), and work in a fume hood to avoid inhalation/dermal exposure.
Avoid contact with skin, eyes, and clothing; prevent aerosol generation. Wash thoroughly after handling.
Incompatibilities: Unknown for this item; as a precaution, segregate from strong oxidizers, strong acids/bases, and reactive reducing agents until specific compatibility is confirmed.
First aid (general): If skin contact occurs, wash with soap and water. If eye exposure, rinse with water for ≥15 min and seek medical attention. If inhaled, move to fresh air. If ingested, rinse mouth; seek medical advice.
Spill/accidental release: Absorb small liquid spills with inert material; for solids, avoid dusting. Dispose per institutional chemical waste procedures.
Thermal/photostability: Unknown; minimize light and heat exposure during handling.
Always consult the product SDS for definitive hazard information and emergency procedures.
Solvent Selection
Without a disclosed structure, solvent choice should be guided empirically with attention to assay compatibility and compound integrity.
Item-specific:
No solubility data provided. Not specified for this item; refer to CoA/Spec Sheet.
General guidance for small molecules:
Primary solvent: DMSO is the default for stock solutions (e.g., 10–50 mM), due to broad solvency and biochemical assay compatibility.
Secondary solvents: DMF, NMP, acetonitrile, ethanol, or methanol can assist in co-solvency at ≤10% v/v in buffer when necessary.
Aqueous buffers: Evaluate surfactant-assisted solubilization (e.g., 0.01–0.05% Tween-20) or protein carriers (0.1% BSA) if allowed by your assay.
pH adjustment: If the compound is ionizable (unknown here), dissolution may improve at pH 2–3 for bases or pH 9–10 for acids; avoid conditions that risk degradation.
Selection tips:
Minimize final DMSO concentration in biological assays (≤0.5–1% v/v) to reduce vehicle effects.
Filter 0.2 µm if particulate persists, provided the compound is not adsorptive to the membrane; perform mass balance checks.
Use amber vials and cold blocks during preparation if photolability/thermolability is suspected.
Storage and Reconstitution
Maintain the integrity of LEO 39652 by following strict cold-chain and handling procedures.
Item-specific (from Product Data):
Storage Conditions: Store at −80 °C.
Shipped In: Dry ice packs + Cold packs.
Reconstitution (general guidance; not item-specific):
If supplied as a solid: Bring container to room temperature in a desiccator before opening to prevent condensation. Prepare a concentrated DMSO stock (e.g., 10–50 mM) under dry conditions. Vortex/sonicate briefly until fully dissolved.
If supplied as a solution: Mix gently after thawing; verify concentration if the CoA provides assayable data.
Aliquoting: Dispense into single-use aliquots (low-bind tubes) to avoid repeated freeze–thaw. Typical aliquots are sized for one experimental day’s use.
Storage after reconstitution (general):
Store DMSO stocks at −20 to −80 °C in amber vials; actual stability is compound-dependent and Not specified for this item. Avoid repeated freeze–thaw; thaw on ice and keep cold during use.
Protect from light and moisture until stability is confirmed.
Stability/expiry:
Shelf life and solution/solid-state stability are Not specified for this item; refer to CoA/Spec Sheet. Conduct periodic LC–MS checks for long-term stored stocks.
Research Use Note: For research use only.
Structure and Identity
Brief overview: LEO 39652 (SKU L654506) is listed as a small-molecule screening compound. Structural identifiers are largely unspecified in the product data.
Item-specific (from Product Data):
Product Name: LEO 39652
SKU: L654506
CAS: 1445656-91-6
PubChem CID: 71611998
InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
Literature/context (general):
The CAS and CID entries indicate a defined small organic molecule, typically suitable for hit discovery and chemogenomic screening. Without a provided structure, detailed functional-group analysis and stereochemical assignment cannot be given here.
Structural description (general note):
2D/3D features, ring systems, functional groups, and stereochemistry are not available in the supplied data. Consult the SDS/CoA or primary database entry (via the provided CAS/CID) for exact structure, including protonation state and tautomer information relevant to assay design.
Synthetic Utility
LEO 39652 is positioned as a screening compound rather than a synthetic building block or reagent.
Item-specific:
Functional group content and reactivity: Not specified for this item; refer to CoA/Spec Sheet.
Applicability (general):
Without structural information, recommending transformations (e.g., cross-coupling handles, nucleophile/electrophile reactivity) is not possible. If structure is available from the provided CAS/CID, you may evaluate derivatization potential for SAR, prodrug design, or bioconjugation.
If repurposed for medicinal chemistry, confirm availability of synthetic routes, stereochemical stability, and handle compatibility (e.g., aryl halides for coupling, amines for amidation) from the literature.
Recommendation:
Treat this material primarily as a reference compound for biological testing; obtain or develop a synthetic route de novo if analogs are needed for SAR expansion.
Target Specificity
Target, mechanism, and selectivity data are not provided for LEO 39652.
Item-specific:
Primary target/pathway: Not specified for this item; refer to CoA/Spec Sheet or original discovery source.
Off-target profile/panel data: Not specified for this item; refer to CoA/Spec Sheet.
General guidance (not item-specific):
Establish apparent potency and specificity using orthogonal biochemical and biophysical assays; confirm with concentration–response curves and appropriate counterscreens.
Evaluate aggregation, redox cycling, and assay interference potential (e.g., inner-filter effects) to avoid false positives.
If phenotypic effects are observed, use target deconvolution methods (chemoproteomics, CRISPR knockouts/knockdowns, rescue experiments) to propose a mechanism.
Foire aux questions
How should this product be stored?
Store at ?80 °C. Ultra-low temperature storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships frozen with dry ice and cold packs. Unpack on arrival and transfer it to the storage condition stated above; handle dry ice with insulated gloves in a ventilated area.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 1445656-91-6, the molecular formula is C23H23N3O5, and the molecular weight is 421.45 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Nous utilisons des cookies pour garantir le bon fonctionnement du site et, lorsque cela est autorisé, pour améliorer votre expérience. Vous pouvez gérer vos préférences à tout moment dans les Paramètres. Pour en savoir plus, consultez notre Politique relative aux cookies.
Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?
Me rappeler plus tard
Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.